Treatment Intensification for Elevated Blood Pressure and Risk of Recurrent Stroke

Beom Joon Kim1, Yong-Jin Cho2, Keun-Sik Hong2

  • 1Department of Neurology and Cerebrovascular Center Seoul National University Bundang HospitalSeoul National University College of Medicine Seongnam Republic of Korea.

Insights

Physicians showing therapeutic inertia in blood pressure management, indicated by low treatment intensification (TI) scores, are linked to a higher risk of recurrent stroke. This highlights TI scores as a potential performance indicator for stroke prevention.

Area of Science:

  • Neurology
  • Cardiology
  • Public Health

Background:

  • Physicians' attitudes towards timely blood pressure management are not fully understood regarding their impact on stroke recurrence risk.
  • Effective blood pressure control is crucial for secondary stroke prevention.

Purpose of the Study:

  • To investigate the association between physicians' attitudes, measured by treatment intensification (TI) scores, and the risk of recurrent stroke.
  • To determine if TI scores can serve as a performance indicator in outpatient settings for stroke prevention.

Main Methods:

  • Analysis of a multicenter stroke registry database of 2933 acute ischemic stroke patients followed for 1 year.
  • Calculation of individual TI scores based on medication changes relative to clinic visits.
  • Use of hierarchical frailty models to assess the association between TI score groups and stroke recurrence, adjusting for covariates.

Main Results:

  • A low TI score, reflecting therapeutic inertia, was significantly associated with an increased risk of recurrent stroke.
  • Patients in TI score groups 1, 2, and 4 showed substantially higher adjusted hazard ratios for recurrent stroke compared to Group 3.
  • The association between low TI scores and elevated stroke recurrence risk persisted across various patient subgroups and clinical settings.

Conclusions:

  • Physicians' therapeutic inertia in managing elevated blood pressure, as indicated by low TI scores, is linked to a higher risk of recurrent stroke.
  • The TI score emerges as a potentially valuable performance metric for outpatient clinics aiming to reduce stroke recurrence.
  • Optimizing blood pressure management through timely treatment intensification is critical for secondary stroke prevention.

Related Concept Videos

Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
243
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
100
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
136
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
306
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
97
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
653